Breast cancer awareness

Targeted Treatment for Advanced Breast Cancer Including CDK4/6 Inhibitor Therapy Reaches Patients in Mozambique for the First Time

Retrieved on: 
Thursday, November 9, 2023

"This is an important day for women living with advanced breast cancer in Mozambique and beyond.

Key Points: 
  • "This is an important day for women living with advanced breast cancer in Mozambique and beyond.
  • For the first time they will be able to access the latest treatment at no cost," said Pat Garcia-Gonzalez, CEO of The Max Foundation.
  • "Access to adequate diagnosis and treatment is paramount to change the survival and the quality of life of patients with advanced breast cancer.
  • Breast cancer is usually diagnosed at late stages, and due to limited resources, patients may receive inadequate treatment, including supportive and palliative care.

GO PINK WITH PILOT PEN AND INK A HEALTHIER FUTURE DURING BREAST CANCER AWARENESS MONTH

Retrieved on: 
Thursday, October 19, 2023

JACKSONVILLE, Fla., Oct. 19, 2023 /PRNewswire/ -- Every day, more than 700 American women are diagnosed with breast cancer. In the spirit of promoting early detection and awareness during Breast Cancer Awareness Month, Pilot Corporation of America (Pilot Pen) is continuing its partnership with the National Breast Cancer Foundation with three of its bestselling pens specially designed with a Breast Cancer Awareness pink ribbon imprinted on the barrel.

Key Points: 
  • In the spirit of promoting early detection and awareness during Breast Cancer Awareness Month, Pilot Corporation of America (Pilot Pen) is continuing its partnership with the National Breast Cancer Foundation with three of its bestselling pens specially designed with a Breast Cancer Awareness pink ribbon imprinted on the barrel.
  • Pilot will donate 10% of gross proceeds from each pink ribbon product sold now through December 31, 2023, up to $130,000, to the National Breast Cancer Foundation for breast cancer education, support and early detection.
  • The Pilot Pink Ribbon line for Breast Cancer Awareness includes:
    Think pink with your ink!
  • Support breast cancer awareness with the smooth writing, long-lasting Pilot G2 Premium Gel Ink Pen.

Dillard’s Launches Breast Cancer Awareness Capsule Collection

Retrieved on: 
Friday, October 13, 2023

Dillard’s, Inc. (“Dillard’s”) (NYSE: DDS) is launching a very special limited-edition Antonio Melani capsule collection during October, Breast Cancer Awareness Month.

Key Points: 
  • Dillard’s, Inc. (“Dillard’s”) (NYSE: DDS) is launching a very special limited-edition Antonio Melani capsule collection during October, Breast Cancer Awareness Month.
  • The line was designed in collaboration with four inspiring and influential breast cancer survivors - with each woman designing her own pieces influenced and inspired by her breast cancer journey.
  • View the full release here: https://www.businesswire.com/news/home/20231010334704/en/
    Stacy Ammon pictured in her dress design for the Antonio Melani X Breast Cancer Awareness Capsule Collection.
  • The Antonio Melani Breast Cancer Awareness capsule collection will be available in select Dillard’s locations in October as well as online at dillards.com.

BLOOMINGDALE'S ANNOUNCES ANNUAL PINK CAMPAIGN WITH THE LAUNCH OF ITS AQUA X KERRI ROSENTHAL COLLECTION

Retrieved on: 
Thursday, September 28, 2023

NEW YORK, Sept. 28, 2023 /PRNewswire/ -- Bloomingdale's today announces AQUA x Kerri Rosenthal, a special collection that serves as an addition to its annual Pink Campaign.  The continuation of the retailer's Give Pink, Get More initiative reinforces its long standing commitment to supporting breast cancer awareness. Over the past 18 years, Bloomingdale's has raised over $17 million for both the Breast Cancer Research Foundation (BCRF) and the Tutu Project.

Key Points: 
  • The retailer's annual Give Pink, Get More campaign will benefit its two long-standing partners, the
    NEW YORK, Sept. 28, 2023 /PRNewswire/ -- Bloomingdale's today announces AQUA x Kerri Rosenthal, a special collection that serves as an addition to its annual Pink Campaign.
  • The 46- piece AQUA x Kerri Rosenthal collection consists of a range of women's and girl's ready-to-wear, seasonal accessories, and home goods inspired by a painting Kerri created exclusively for Bloomingdale's in honor of Breast Cancer Awareness.
  • We are honored to now layer in yet another element to the activity this season with the launch of AQUA X Kerri Rosenthal."
  • Additional information on the Bloomingdale's PINK Campaign can be found HERE , and information on local PINK Yoga and PINK Party events can be found on Eventbrite in select markets.

ScreenPoint Medical Showcases Global Momentum for Transpara(R) Breast AI at EUSOBI

Retrieved on: 
Thursday, September 28, 2023

VALENCIA, Spain, Sept. 28, 2023 /PRNewswire/ -- ScreenPoint Medical is showcasing global momentum for Transpara, the world's leading Breast artificial intelligence (AI) software, here at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting, September 28-30, 2023 (Booth M02). 

Key Points: 
  • VALENCIA, Spain, Sept. 28, 2023 /PRNewswire/ -- ScreenPoint Medical is showcasing global momentum for Transpara, the world's leading Breast artificial intelligence (AI) software, here at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting, September 28-30, 2023 (Booth M02).
  • Headlining the publications are preliminary results from the first randomized controlled trial in Breast AI: the Mammography Screening with AI (MASAI) Study published this summer in Lancet Oncology.
  • Results on prior mammograms with a Transpara score of 10 illustrate the potential for earlier detection of breast cancers by using AI in screen-reading.
  • These studies have validated Transpara's performance in helping radiologists detect cancer earlier and safely reduce workload," said Mark Koeniguer, ScreenPoint Medical CEO.

Go Pink! Mellow Mushroom Supports Breast Cancer Research

Retrieved on: 
Tuesday, September 26, 2023

“We want to make an impact in the fight against breast cancer in a very Mellow way,” says Anne Mejia, Vice President of Brand Development at Mellow Mushroom. “Mellow Mushroom’s beverage team crafted a uniquely pink cocktail -- using Casamigos Reposado as its key ingredient -- and our culinary team transformed our popular pretzel munchie into a ‘breast cancer’ ribbon to make a very Mellow impact on this important cause.”

Key Points: 
  • (Photo: Business Wire)
    Starting September 26th and throughout the month of October, Mellow Mushroom will be going pink in a big way:
    Pretzels will be reshaped to represent the pink ribbons associated with Breast Cancer Awareness.
  • “We want to make an impact in the fight against breast cancer in a very Mellow way,” says Anne Mejia, Vice President of Brand Development at Mellow Mushroom.
  • Mellow Mushroom has also created breast cancer ribbon-shaped pretzels to accompany the cocktail.
  • When you enjoy Mellow Mushroom this fall, you'll also be helping to create a world without breast cancer - it's a win-win!”
    Since 1982, Susan G. Komen has donated $1.1B to breast cancer research and supports the more than four million breast cancer survivors and those living with breast cancer in the U.S.

The Max Foundation to Launch Treatment Access for Advanced Breast Cancer in Nine Countries Across Africa, Latin America, and South Asia in Q3 2023

Retrieved on: 
Thursday, June 1, 2023

Max is working in collaboration with multiple partners to implement the program through its Humanitarian Partnership for Access to Cancer Treatment (Humanitarian PACT) for Advanced Breast Cancer.

Key Points: 
  • Max is working in collaboration with multiple partners to implement the program through its Humanitarian Partnership for Access to Cancer Treatment (Humanitarian PACT) for Advanced Breast Cancer.
  • Partners in the Humanitarian PACT for Advanced Breast Cancer have agreed to invest resources and/or their unique knowledge and capabilities to support the expansion of Max Access Solutions to provide access to treatment for HR+/HER2- advanced breast cancer.
  • Close to than 45,000 people have received access to treatment through Max Access Solutions, which now operates in over 70 low-resource countries.
  • Breast cancer is the most common cancer in women with 25% of all cancers diagnosed in women being breast cancer.

Artificial Intelligence from ScreenPoint Medical and Volpara Health Demonstrates Ability to Predict Long-Term Breast Cancer Risk

Retrieved on: 
Tuesday, May 23, 2023

NIJMEGEN, Netherlands and WELLINGTON, New Zealand, May 23, 2023 /PRNewswire/ -- Researchers from the Mayo Clinic (Rochester, MN) and University of California, San Francisco confirmed that pairing artificial intelligence (AI) imaging and volumetric breast density algorithms can assist in predicting long-term risk of breast cancer, in particular invasive disease. The study, "Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer," was recently published in the Journal of Clinical Oncology.

Key Points: 
  • The study, " Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer ," was recently published in the Journal of Clinical Oncology.
  • Researchers used images from 2,412 women with invasive breast cancer and 4,995 matched controls who had digital mammograms performed 2-5.5 years before cancer diagnosis.
  • Transpara AI score improves long-term risk prediction when combined with clinical risk factors including breast density for overall invasive cancers, screen-detected, advanced, and nonadvanced cancers.
  • ScreenPoint Medical translates cutting edge machine learning research into technology accessible by radiologists to improve screening workflow, decision confidence and breast cancer risk assessment.

Artificial Intelligence from ScreenPoint Medical and Volpara Health Demonstrates Ability to Predict Long-Term Breast Cancer Risk

Retrieved on: 
Tuesday, May 23, 2023

NIJMEGEN, Netherlands and WELLINGTON, New Zealand, May 23, 2023 /PRNewswire/ -- Researchers from the Mayo Clinic (Rochester, MN) and University of California, San Francisco confirmed that pairing artificial intelligence (AI) imaging and volumetric breast density algorithms can assist in predicting long-term risk of breast cancer, in particular invasive disease. The study, "Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer," was recently published in the Journal of Clinical Oncology.

Key Points: 
  • The study, " Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer ," was recently published in the Journal of Clinical Oncology.
  • Researchers used images from 2,412 women with invasive breast cancer and 4,995 matched controls who had digital mammograms performed 2-5.5 years before cancer diagnosis.
  • Transpara AI score improves long-term risk prediction when combined with clinical risk factors including breast density for overall invasive cancers, screen-detected, advanced, and nonadvanced cancers.
  • ScreenPoint Medical translates cutting edge machine learning research into technology accessible by radiologists to improve screening workflow, decision confidence and breast cancer risk assessment.

CURE Media Group announces Abbey Kaler, MS, APRN, FNP-C, CMSRN, as winner of 2023 Extraordinary Healer® Award

Retrieved on: 
Thursday, April 27, 2023

SAN ANTONIO, Texas, April 27, 2023 (GLOBE NEWSWIRE) -- CURE®, the industry-leading multimedia platform devoted to cancer updates and research that reaches more than 1 million patients, survivors and caregivers, has named Abbey Kaler, MS, APRN, FNP-C, CMSRN, the winner of the 2023 Extraordinary Healer award. At an awards ceremony at the San Antonio Marriott Rivercenter on the River Walk, Kaler was recognized for her tremendous dedication, expertise and helpfulness in caring for patients. Shannon Miller, seven-time Olympic medalist and cancer survivor, served as the event’s keynote speaker.

Key Points: 
  • Photo credit: Tammy Blalock
    “We are honored to celebrate the exceptional oncology nurses who demonstrate unwavering commitment to their patients,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences®, the parent company of CURE Media Group.
  • Kaler earned a Bachelor of Science degree in nursing at Baptist Health Sciences University in Memphis, Tennessee.
  • Founded in 2007, the annual Extraordinary Healer award has received hundreds of nominations and it continues to grow each year.
  • The men and women honored by the award have been nominated by colleagues, patients, friends, and family of outstanding oncology nurses throughout the country.